Literature DB >> 11507233

Jaagsiekte sheep retrovirus Env protein stabilizes retrovirus vectors against inactivation by lung surfactant, centrifugation, and freeze-thaw cycling.

D A Coil1, J H Strickler, S K Rai, A D Miller.   

Abstract

Jaagsiekte sheep retrovirus (JSRV) replicates in the lungs of sheep and causes the secretion of copious lung fluid containing the virus. Adaptation of JSRV to infection and replication in the lung and its apparent resistance to the denaturing activity of lung fluid suggest that vectors based on JSRV would be useful for gene therapy targeted to the lung. We show here that a retrovirus vector bearing the JSRV Env is stable during treatment with lung surfactant while an otherwise identical vector bearing an amphotropic Env is inactivated. Furthermore, the JSRV vector was stable during centrifugation, allowing facile vector concentration, and showed no loss of activity after six freeze-thaw cycles. However, the JSRV vector was inactivated by standard disinfectants, indicating that JSRV vectors pose no unusual safety risk related to their improved stability under other conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507233      PMCID: PMC115133          DOI: 10.1128/jvi.75.18.8864-8867.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

Review 1.  Gene transfer for cystic fibrosis.

Authors:  M J Welsh
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  Retrovirus vectors bearing jaagsiekte sheep retrovirus Env transduce human cells by using a new receptor localized to chromosome 3p21.3.

Authors:  S K Rai; J C DeMartini; A D Miller
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.

Authors:  B G Harvey; P L Leopold; N R Hackett; T M Grasso; P M Williams; A L Tucker; R J Kaner; B Ferris; I Gonda; T D Sweeney; R Ramalingam; I Kovesdi; S Shak; R G Crystal
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

4.  Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions.

Authors:  K Toyoshima; P K Vogt
Journal:  Virology       Date:  1969-07       Impact factor: 3.616

5.  Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect.

Authors:  G Wang; V Slepushkin; J Zabner; S Keshavjee; J C Johnston; S L Sauter; D J Jolly; T W Dubensky; B L Davidson; P B McCray
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

6.  Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro.

Authors:  J E Duncan; J A Whitsett; A D Horowitz
Journal:  Hum Gene Ther       Date:  1997-03-01       Impact factor: 5.695

7.  Keratinocyte growth factor stimulates transduction of the respiratory epithelium by retroviral vectors.

Authors:  Z K Zsengellér; C Halbert; A D Miller; S E Wert; J A Whitsett; C J Bachurski
Journal:  Hum Gene Ther       Date:  1999-02-10       Impact factor: 5.695

Review 8.  Gene therapy for lung disease: hype or hope?

Authors:  S M Albelda; R Wiewrodt; J B Zuckerman
Journal:  Ann Intern Med       Date:  2000-04-18       Impact factor: 25.391

9.  Jaagsiekte sheep retrovirus is necessary and sufficient to induce a contagious lung cancer in sheep.

Authors:  M Palmarini; J M Sharp; M de las Heras; H Fan
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

10.  Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure.

Authors:  C L Halbert; T A Standaert; C B Wilson; A D Miller
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  7 in total

1.  Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells.

Authors:  Lucas Chan; Darren Nesbeth; Taylor Mackey; Joanna Galea-Lauri; Joop Gäken; Francisco Martin; Mary Collins; Ghulam Mufti; Farzin Farzaneh; David Darling
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  Enhanced proliferation of primary rat type II pneumocytes by Jaagsiekte sheep retrovirus envelope protein.

Authors:  Chassidy Johnson; Sohail Jahid; Dennis R Voelker; Hung Fan
Journal:  Virology       Date:  2011-02-12       Impact factor: 3.616

3.  Expression and characterization of a soluble, active form of the jaagsiekte sheep retrovirus receptor, Hyal2.

Authors:  Vladimir Vigdorovich; Roland K Strong; A Dusty Miller
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Fusogenicity of Jaagsiekte sheep retrovirus envelope protein is dependent on low pH and is enhanced by cytoplasmic tail truncations.

Authors:  Marceline Côté; Yi-Min Zheng; Lorraine M Albritton; Shan-Lu Liu
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

5.  Jaagsiekte sheep retrovirus envelope efficiently pseudotypes human immunodeficiency virus type 1-based lentiviral vectors.

Authors:  Shan-Lu Liu; Christine L Halbert; A Dusty Miller
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 6.  Current status of gene therapy for inherited lung diseases.

Authors:  Ryan A Driskell; John F Engelhardt
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

7.  Evidence against a role for jaagsiekte sheep retrovirus in human lung cancer.

Authors:  A Dusty Miller; Marcelo De Las Heras; Jingyou Yu; Fushun Zhang; Shan-Lu Liu; Andrew E Vaughan; Thomas L Vaughan; Raul Rosadio; Stefano Rocca; Giuseppe Palmieri; James J Goedert; Junya Fujimoto; Ignacio I Wistuba
Journal:  Retrovirology       Date:  2017-01-20       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.